Press Releases

and/or
568 News Releases found
Memorial Sloan Kettering President and CEO Craig B. Thompson, MD
Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor.
Nikolaus Schultz, PhD
A new study from Memorial Sloan Kettering Cancer Center (MSK) provides important insights into cancer metastasis.  
Ghassan Abou-Alfa, MD
New study results found that patients who received a combination of the immunotherapy drugs durvalumab and tremelimumab significantly improved overall survival
MSK Awards & Appointments January 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Rémy Evard
Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Fiona and Stanley Druckenmiller
Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.
MSK Awards & Appointments December 2021
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Gilles Salles
The research was published in the New England Journal of Medicine and presented at the American Society of Hematology (ASH) Annual Meeting and Exposition.
Andrea Barrio, MD
Researchers found that Black race was the strongest predictor of lymphedema development with a 3.5-fold increased incidence of lymphedema in Black women compared to White women.
Saad Usmani, MD
Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.